Judy Henry: From Herbalist to Entrepreneur

Sep.08.2022
Judy Henry: From Herbalist to Entrepreneur
Judy Henry, Idaho entrepreneur, developed all-natural formulas mimicking addictive nicotine and SARMS, but is unable to sell due to FDA regulations.

Judy Henry, an entrepreneur from Idaho, USA, has had a lifelong passion for plants and herbs. She spent several years researching the benefits of herbal medicine for health and has developed it into a lifelong career.


I use plant-based products because I grew up with them and understand what they can do for our bodies," Henry said during the interview.


I truly believe that God has placed everything we need on this earth," she continued. "They are the culmination of knowledge from previous generations who embraced plant medicine because of the powerful impact it has on our overall well-being.


This belief guides the life of Judy Henry. Furthermore, this belief has developed into something unique for her. Sacred Body Botanicals is the result of her dedication. Her accomplishment is building a small, natural health and wellness brand, which ultimately grew into a laboratory for innovative products developed over the years.


As a former smoker, Henry saw an opportunity to improve health. Utilizing her expertise in herbal medicine, she created a series of all-natural formulas to mimic the pleasure of addictive nicotine. Henry patented several of these formulas, stating that they have attracted a broad customer base who have seen benefits in a short period of time.


One of the products is a nicotine-free e-liquid, which Henry claims is a nicotine detoxifier that can help people quit smoking.


She developed the NoNic product, which has had a promising start. She also launched a pilot program in the local community to offer workshops introducing customers to her NoNic product.


She said she has had success introducing her NoNic formula to clients struggling with nicotine addiction in a few short meetings. Henry pointed out that due to FDA regulations, the product has not undergone medical review and she cannot promote its health benefits. However, she said some of her clients have provided positive feedback. One story she shared with me was particularly notable. A gentleman started using the NoNic formula and claimed he immediately became addicted to it, never smoking again. She has seen real-life success with NoNic.


However, the harsh reality is that selling plant-based formulations in the United States is illegal without invasive and expensive FDA inspections and approvals or other bans on products not federally approved. Despite creating a product that is almost entirely different from others on the market, the law forbids Henry from selling NoNic through her company, Sacred Body Botanicals.


In 2020, the United States Congress passed the controversial Preventing Online Sales of E-Cigarettes to Children Act, which amended the Prevent All Cigarette Trafficking (PACT) Act of 2009. The new law allows the Federal Alcohol, Tobacco, and Firearms (ATF) agency to actively enforce rules governing the interstate sale of tobacco products. The Preventing Online Sales of E-Cigarettes to Children Act expands upon the existing PACT Act by including a broad definition that encompasses e-cigarette devices and includes a ban on e-cigarette mailings enforced by the United States Postal Service.


Disclaimer: 1. This article is compiled from third-party information, and is only provided for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article content. The compilation of this article is only for industry exchange and research. 3. Due to the limitations of compilation skills, the compiled article may not express the same meaning as the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macau, Taiwan, or foreign statements and positions, 2FIRSTS fully aligns with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Group, Inc. announced the nationwide retail expansion of on! PLUS nicotine pouches, a product manufactured by Helix Innovations LLC, an Altria operating company. The product had already been available through e-commerce and participating retailers in North Carolina, Florida and Texas, began wholesale deliveries on March 16, 2026, and is expected to reach participating retailers nationwide starting March 23, 2026.
Mar.24 by 2FIRSTS.ai
Focus on Regulation and Taxation: EVO NXT 2026 Provides Strategic Guidance for Decision-Makers
Focus on Regulation and Taxation: EVO NXT 2026 Provides Strategic Guidance for Decision-Makers
The NGP industry faces rising innovation pressure, growing consumer demand and intensifying regulatory dynamics. Sustainable growth now depends on reliable market intelligence, strong partnerships and structured dialogue with policymakers and stakeholders. On 17–18 April 2026 in Prague, EVO NXT will convene manufacturers, retailers, distributors and industry experts for strategic exchange, with this year’s conference placing regulation and taxation firmly at the center of discussion.
Mar.02
Cyprus Bill to Regulate Nicotine Pouches Expected to Reach House Plenary in Early April
Cyprus Bill to Regulate Nicotine Pouches Expected to Reach House Plenary in Early April
A proposed law to regulate nicotine pouches in Cyprus is expected to reach the House plenary session in early April. The bill, submitted by Diko MP Chrysis Pantelidis, aims to establish a regulatory framework governing the marketing, composition and quality of nicotine pouches currently circulating on the market and to incorporate them into existing smoking control legislation.
Mar.13 by 2FIRSTS.ai
Special Report|Disposable Heated Tobacco? A China Tobacco Patent Reimagines the Heated-Tobacco Stick as a Self-Contained Product
Special Report|Disposable Heated Tobacco? A China Tobacco Patent Reimagines the Heated-Tobacco Stick as a Self-Contained Product
A newly published China Tobacco patent proposes a holder-free heat-not-burn stick that integrates the filter, tobacco substrate, heating element, controller and power source into one cigarette-shaped product. It stands out not just for eliminating the external heating device, but for explicitly highlighting two less common goals in heated tobacco: restoring cigarette-like social sharing and enabling post-use recovery through a recoverable component group.
Innovation
Mar.18
PMI’s Portuguese unit to launch nicotine pouches in 2026 after tax clarification
PMI’s Portuguese unit to launch nicotine pouches in 2026 after tax clarification
After Portugal included nicotine pouches in the excise-tax (IEC) framework for tobacco and nicotine products, PMI’s Portuguese subsidiary Tabaqueira confirmed it will begin selling nicotine pouches in the country this year. The company is preparing a soft launch in two stores ahead of wider distribution, as the tax and regulatory position becomes clearer.
Mar.10 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24